AMZN
Amazon.com, Inc.
AMZN has the edge over JILL overall, supported by stronger valuation and stronger modeled upside.
JILL
J.Jill, Inc.
JILL's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
JILL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
JILL's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over JILL in the historical PE scenario, which offers more potential upside but is not a forecast.
JILL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $11.88 | -47% |
| Fair | 8.9x | $15.86 | -29% |
| Forward | 9.5x | $22.43 | — |
| Expensive | 13x | $22.75 | +1.4% |
| Current | 13x | $22.43 | — |
Historical ranges are pointers, not guarantees.
JILL's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 9.5x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
JILL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
JILL has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over JILL on earnings, with more consistent year-over-year improvement.
JILL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.37 | +33% |
| Q3 2026 | $1.79 | -24% |
| Q2 2026 | $1.37 | -38% |
| Q1 2026 | $1.82 | -30% |
| Q4 2025 | $2.16 | -24% |
| Q3 2025 | $2.36 | -17% |
| Q2 2025 | $2.21 | -34% |
| Q1 2025 | $2.61 | +4% |
| Q4 2024 | $2.83 | +26% |
JILL's earnings per share have fallen from their peak: $1.79 over the past year, against $3.88 in mid-2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over JILL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
JILL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $154.8M | +0.5% |
| Q2 2026 | $144.4M | -6% |
| Q1 2026 | $138.4M | -3.1% |
| Q4 2025 | $150.5M | -0.5% |
| Q3 2025 | $154M | -0.8% |
| Q2 2025 | $153.6M | -4.9% |
| Q1 2025 | $142.8M | -4.4% |
| Q4 2024 | $151.3M | +0.8% |
JILL's revenue grew through 2021 and has held roughly level since: $155M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +4.8 points |
| Q2 2026 | 6.1% | -6.3 points |
| Q1 2026 | -0.1% | -3.7 points |
| Q4 2025 | 9.9% | -2.8 points |
| Q3 2025 | 11% | -3.9 points |
| Q2 2025 | 12% | -5.2 points |
| Q1 2025 | 3.6% | -3.5 points |
| Q4 2024 | 13% | -2 points |
JILL has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
JILL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.5M | +160% |
| Q2 2026 | -$881K | -128% |
| Q1 2026 | -$11M | -899% |
| Q4 2025 | $16M | +9.4% |
| Q3 2025 | $17.1M | +14% |
| Q2 2025 | $3.1M | -84% |
| Q1 2025 | $1.4M | -22% |
| Q4 2024 | $14.6M | -22% |
JILL has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
JILL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +98.7K shares |
| 1 year | -1.5% | -223K shares |
| 3 years | +3.9% | +564K shares |
| 5 years | +65% | +5.9M shares |
| Available history | +71% | +6.3M shares |
JILL has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.5M |
| Q2 2026 | $794,000 |
| Q1 2026 | $3.8M |
| Q4 2025 | $2M |
| Q3 2025 | $1M |
| Q2 2025 | $3.5M |
JILL spent $8M buying back its own shares over the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
JILL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q4 2024 | 0.3x | Very low |
| Q3 2024 | 0.4x | Very low |
JILL has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
JILL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.0 | Neutral |
| Stochastic | 69.5 | Neutral |
JILL's weekly RSI is 60 (neutral) and its Stochastic is 70 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
JILL PE vs Consumer Cyclical Sector
| Metric | JILL | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 30% below |
| PE % | 81 | 47 | 34 pts above |
JILL has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over JILL on trend strength, trading above more of its moving averages.
JILL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.7 | 5.5% below |
| 20 week MA | $21.0 | 6.8% above |
| 50 week MA | $17.1 | 31% above |
| 100 week MA | $17.8 | 26% above |
| 200 week MA | $22.4 | 0% above |
JILL has slipped below its 8-week average, but it's still above the other four, and 0% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
JILL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.50 | $4.02 | -27% |
| 2021 | $4.02 | $16.8 | +319% |
| 2022 | $16.8 | $22.5 | +34% |
| 2023 | $22.5 | $25.8 | +14% |
| 2024 | $25.8 | $26.9 | +4.3% |
| 2025 | $26.9 | $14.5 | -46% |
| 2026 YTD | $14.5 | $22.4 | +55% |
JILL has the edge over AMZN on returns for 2026, with the stronger performance.